Shankar Musunuri
Chief Executive Officer en OCUGEN, INC. .
Fortuna: 5 M $ al 31/03/2024
Cargos activos de Shankar Musunuri
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OCUGEN, INC. | Chief Executive Officer | 27/09/2019 | - |
| Chairman | 27/09/2019 | - | |
| Founder | 01/01/2013 | - | |
| Director of Finance/CFO | 15/08/2023 | 15/09/2023 | |
| Ocugen OpCo, Inc. | Chief Executive Officer | 01/05/2015 | - |
| Chairman | 01/09/2013 | - | |
| Founder | 01/09/2013 | - |
Historial de carrera de Shankar Musunuri
Antiguos cargos conocidos de Shankar Musunuri.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/1996 | 01/01/2010 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/1996 | 01/01/1996 |
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Chief Executive Officer | 01/01/2013 | - |
| Chairman | 01/01/2013 | - | |
| Founder | 01/01/2013 | - | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - | - |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Director/Board Member | 01/01/2009 | - |
| Chief Executive Officer | 01/01/2009 | 18/10/2013 | |
| Founder | 01/01/2009 | - | |
| President | 01/01/2009 | 18/10/2013 |
Formación de Shankar Musunuri.
| University of Connecticut | Doctorate Degree |
| The Fuqua School of Business | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Chief Executive Officer | 4 |
| Founder | 4 |
| Corporate Officer/Principal | 3 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Health Technology |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
- Bolsa de valores
- Insiders
- Shankar Musunuri
- Experiencia
